Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 10, 2020

ANI Pharmaceuticals Reports Second Quarter 2020 Results

Business Wire August 6, 2020

ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors

Business Wire August 6, 2020

ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer

Business Wire August 3, 2020

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results

Business Wire July 30, 2020

ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets

PR Newswire July 6, 2020

ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules

PR Newswire June 30, 2020

ANI Pharmaceuticals Provides Update on Recent Regulatory Filing

PR Newswire June 1, 2020

ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO

PR Newswire May 7, 2020

ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results

PR Newswire April 30, 2020

ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel

PR Newswire April 29, 2020

ANI Announces Upcoming Departure of CEO

PR Newswire April 14, 2020

ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL

PR Newswire April 13, 2020

ANI Pharmaceuticals Announces Launch of Omega-3-Acid Ethyl Esters Capsules USP

PR Newswire April 2, 2020

ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet

PR Newswire March 26, 2020

ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL

PR Newswire March 24, 2020

ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules

PR Newswire March 2, 2020

ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020

PR Newswire February 27, 2020

ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results

PR Newswire February 20, 2020

ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL

PR Newswire February 12, 2020